Third Software Earns AASM Autoscoring Certification

Summary: The American Academy of Sleep Medicine launched the Autoscoring Certification: Sleep Stage Pilot Program in 2023. SOMNOmedics’ DOMINO v 3.0 software recently earned this certification, joining certified software programs from Philips Respironics and EnsoData.  Key Takeaways:  AASM Autoscoring Certification Program: The program assesses autoscoring software to ensure it meets high standards of accuracy and…

Read More

Hypoxia-Like Conditions Identified in People with Down Syndrome

Summary: A study has identified hypoxia-like conditions in individuals with Down syndrome. The research found significant changes in gene expression and protein levels related to oxygen availability and red blood cell function, suggesting a physiological state similar to low oxygen, or hypoxia. This state may contribute to common health issues in people with Down syndrome,…

Read More

CPSC Warns Against Baby Loungers Linked to Five Infant Deaths

Summary: The US Consumer Product Safety Commission (CPSC) has issued a warning for consumers to immediately stop using and destroy five brands of baby loungers—Mamibaby, Yoocaa, DHZJM, Cosy Nation, and Hyhuudth—due to significant risks of suffocation, entrapment, and falls. These hazards have been linked to five infant deaths. Despite these risks, the manufacturer has not…

Read More

Movano Health Focuses on Evie Ring Restock and FDA Clearance

Summary: Movano Health, the maker of the Evie Ring, reported its second-quarter 2024 financial results and provided a business update. The company is focusing on relaunching the Evie Ring, securing FDA 510(k) clearance for its EvieMED Ring, and advancing clinical studies on cuffless blood pressure and noninvasive glucose monitoring. Movano Health also highlighted several business-to-business…

Read More

Vivos Secures Medicare Reimbursement and Launches New Marketing Strategy in Q2

Summary: Vivos Therapeutics reported milestones in its second quarter, including securing Medicare reimbursement approval for its CARE oral appliances, launching a new marketing and distribution strategy, and closing a $7.5 million equity growth investment. Additionally, Vivos announced positive results from a multi-site marketing pilot and that over 45,000 patients have been treated with Vivos OSA…

Read More